leadf
logo-loader
Seelos Therapeutics - Psychedelics are bursting into the mainstream as a promising medical treatment Companies are starting to bet big on psychedelic drugs to treat US mental health epidemic

Once dismissed as a "party drug" for its hallucinogenic effects, ketamine is emerging as a novel...

on 5/6/20
Feature

Psychedelic medicines: Startups and innovators set the pace on trip to...

Taking the active ingredients of psychedelics and proving their effectiveness in the clinic...

on 4/6/20
Feature

Does ATAI Life Sciences' 'biotech platform' provide the antidote to...

Set up two years ago, it has attracted more than US$100mln in Series A and B funding that has...

on 19/5/20
Deep dive

Seelos has catalysts for its ketamine depression drug, multiple shots on...

The New York clinical-stage biopharmaceutical company has several drugs in the pipeline capable...

on 17/2/20
Deep dive

Codebase Ventures takes aim at investing in early-stage technology, cannabis...

Portfolio includes blockchain firm Arcology, Pressland, which is dedicated to fighting fake...

on 23/9/19

Albert Labs looking to investigate the use of psychedelics to treat anxiety...

Albert Labs Chief Medical Officer Dr. Malcom Barratt-Johnson joined Steve Darling from Proactive to share details about the private company with a focus on the emerging field of psychedelic-assisted therapy and research. Dr. Barratt-Johnson talks about the origins of Albert Labs and about their...

on 26/1/21